Effects of altered Bcl-2 expression on B lymphocyte selection

Annals of the New York Academy of Sciences

Volumn 815, Issue , 1997, Pages 40-54

  Mandik, Laura ^a   Katsumata, Makoto ^b   Erikson, Jan ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL SURFACE PROTEIN; IMMUNOGLOBULIN LIGHT CHAIN; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; CELL DEATH; CELL MATURATION; CELL SELECTION; CONFERENCE PAPER; CONTROLLED STUDY; ETIOLOGY; FLOW CYTOMETRY; KIDNEY DISEASE; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPLEEN; STAIN; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALIA;

EID: 0030791575     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52043.x     Document Type: Conference Paper

References (43)

1. Izui, S., V. E. KELLEY, K. MASUDA, H. YOSHIDA, J. B. ROTHS & E. D. MURPHY. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133: 227-233.
2. COHEN, P. L. & R. A. EISENBERG. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269.
3. THEOFILOPOULOS, A. N. & F. J. DIXON. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
4. PISETSKY, D. S., S. A. CASTER, J. B. ROTHS & E. D. MURPHY. 1982. Lpr gene control of the anti-DNA antibody response. J. Immunol. 128: 2322-2325.
5. WATANABE-FUKUNAGA, R., C. I. BRANNAN, N. G. COPELAND, N. A. JENKINS & S. NAGATA. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
6. CHU, J-L., J. DRAPPA, A. PARNASSA & K. B. ELKON. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, Etn. J. Exp. Med. 178: 723-730.
7. WU, J., T. ZHOU, J. HE & J. D. MOUNTZ. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178: 461-468.
8. MANDIK, L., K-A. T. NGUYEN & J. ERIKSON. 1995. Fas receptor expression on B-lineage cells. Eur. J. Immunol. 25: 3148-3154.
9. ONEL, K. B., C. L. TUCEK-SZABO, D. ASHANY, E. LACY, J. NIKOLIC-ZUGIC & K. B. ELKON. 1995. Expression and function of the murine CD95/FasR/APO-l receptor in relation to B cell ontogeny. Eur. J. Immunol. 25: 2940-2947.
10. DRAPPA, J., N. BROT & K. B. ELKON. 1993. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice, but not in the lupus-prone strain MRL-lpr/lpr. Proc. Natl. Acad. Sci. U.S.A. 90: 10340-10344.
11. ROTHSTEIN, T. L., J. K. M. WANG, D. J. PANKA, L. C. FOOTE, Z. WANG, B. STANGER, H. CUR, S-T. JU & A. MARSHAK-ROTHSTEIN. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163-165.
12. WANG, J., I. TANUCHI, Y. MAEKAWA, M. HOWARD, M. D. COOPER & T. WATANABE. 1996. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 26: 92-96.
13. MERINO, R., L. DING, D. J. VEIS, S. J. KORSMEYER & G. NUNEZ. 1994. Developmental regulation of the bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13: 683-691.
14. HOCKENBERRY, D. M., M. ZUTTER, W. HICKEY, M. NAHM & S. J. KORSMEYER. 1991. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 88: 6961-6965.
15. LIU, Y-J., D. Y. MASON, G. D. JOHNSON, S. ABBOT, C. D. GREGORY, D. L. HARDIE, J. GORDON & I. M. MACLENNAN. 1991. Germinal center B cells express bcl-2 protein after activation signals which prevent their entry into apoptosis. Eur. J. Immunol. 21: 1905-1910.
16. TSUJIMOTO, Y., L. R. FINGER, J. YUNIS, P. C. NOWELL & C. M. CROCE. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) translocation. Science 226: 1097-1099.
17. H on chromosome 14 and near a transcriptional unit of 18. Cell 41: 899-906.
18. CORY, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13: 513-543.
19. ITOH, N., Y. TSUJIMOTO & S. NAGATA. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151: 621-627.
20. ENARI, M., A. HASE & S. NAGATA. 1995. Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14: 5201-5208.
21. CHIU, V. K., C. M. WALSH, C-C. LIU, J. C. REED & W. R. CLARK. 1995. Bcl-2 blocks degranulation, but not Fas-based cell-mediated cytotoxicity. J. Immunol. 154: 2023-2032.
22. LACRONIQUE, V., A. MIGNON, M. FABRE, B. VIOLLET, N. ROUQUET, T. MOLINA, A. PORTEU, A. HENRION, D. BOUSCARY, P. VARLET, V. JOULIN & A. KAHN. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Med. 2: 80-86.
23. RODRIGUEZ, I., K. MATSUURA, K. KHATIB, J. C. REED, S. NAGATA & P. VASSALLI. 1996. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction, but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183: 1031-1036.
24. STRASSER, A., S. WHITTINGHAM, D. L. VAUX, M. L. BATH, J. M. ADAMS, S. CORY & A. W. HARRIS. 1991. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody response and elicits autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 88: 8661-8665.
25. MCDONNELL, T. J., N. DEANE, F. M. PLATT, G. NUNEZ, U. JAEGER, J. P. MCKEARN & S. J. KORSMEYER. 1989. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-88.
26. KATSUMATA, M., R. M. SIEGEL, D. C. LOUIE, T. MIYASHITA, Y. TSUJIMOTO, P. C. NOWELL, M. I. GREENE & J. C. REED. 1992. Differential effects of bcl-2 on T and B cells in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 89: 11376-11380.
27. H family repertoire in bcl-2-Ig transgenic mice. Int. Immunol. 3: 1329-1333.
28. HARTLEY, S. B., M. P. COOKE, D. A. FULCHER, A. W. HARRIS, S. CORY, A. BASTEN & C. C. GOODNOW. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72: 325-335.
29. NISITANI, S., T. TSUBATA, M. MURAKAMI, M. OKAMOTO & T. HONJO. 1993. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery, but not in the bone marrow. J. Exp. Med. 178: 1247-1254.
30. ERIKSON, J., M. Z. RADIC, S. A. CAMPER, R. R. HARDY, C. CARMACK & M. WEIGERT. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349: 331-334.
31. HARDY, R. R., C. E. CARMACK, S. A. SHINTON, J. D. KEMP & K. HAYAKAWA. 1991. Resolution and characterization of pro-B and pre-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213-1225.
32. REAP, E. A., N. J. FELIX, P. A. WOLTHUSEN, B. L. KOTZIN, P. L. COHEN & R. A. EISENBERG. 1995. Bcl-2 transgenic mice show profound enhancement of lymphadenopalhy. J. Immunol. 155: 5455-5462.
33. STRASSER, A., A. W. HARRIS, D. L. VAUX, E. WEBB, M. L. BATH, J. M. ADAMS & S. CORY. 1990. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166: 175-181.
34. H element reading frame selection is influenced by an Ig heavy chain transgene, but not by bcl-2. J. Immunol. 154: 3341-3350.
35. STRASSER, A., A. W. HARRIS & S. CORY. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899.
36. MCDONNELL, T. J., G. NUNEZ, F. M. PLATT, D. HOCKENBERRY, L. LONDON, J. P. MCKEARN & S. J. KORSMEYER. 1990. Deregulated bcl-2-immunoglobulin transgene expands a resting, but responsive immunoglobulin M and D-expressing B cell population. Mol. Cell. Biol. 10: 1901-1907.
37. PAUZA, M. E., J. A. REHMANN & T. W. LEBIEN. 1993. Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express surface κ and λ light chains. J. Exp. Med. 178: 139-149.
38. ROARK, J. H., C. L. KUNTZ, K-A. NGUYEN, A. J. CATON & J. ERIKSON. 1995. Breakdown of B cell tolerance in a mouse model of SLE. J. Exp. Med. 181: 1157-1167.
39. TSAO, B. P., K. OHNISHI, H. CHEROUTRE, B. MITCHELL, M. TEITELL, P. MIXTER, M. KRONENBERG & B. H. HAHN. 1992. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J. Immunol. 149: 350-358.
40. OFFEN, D., L. SPATZ, H. Escowrrz, S. FACTOR & B. DIAMOND. 1992. Induction of tolerance to an IgG autoantibody. Proc. Natl. Acad. Sci. U.S.A. 89: 8332-8336.
41. IMANISHI-KARI, T., S. BANDYOPADHAY, P. BUSTO & C. A. HUANG. 1993. Endogenous Ig production in μ transgenic mice. J. Immunol. 150: 3311-3326.
42. STRASSER, A., A. W. HARRIS, D. C. S. HUANG, P. H. KRAMMER & S. CORY. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147.
43. TAN, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93-151.